| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |